IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Overview of attention for article published in BMC Cancer, May 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,477 followers.

RT @cancerscnews: IFI44L Is a Novel Tumor Suppressor in Human #HepatocellularCarcinoma Affecting Cancer Stemness, Metastasis, & Drug Resist…

IFI44L Is a Novel Tumor Suppressor in Human #HepatocellularCarcinoma Affecting Cancer Stemness, Metastasis, & Drug Resistance via Regulating met/Src Signaling Pathway @ICR_London https://t.co/AYBI0CLJzX

RT @BMC_series: IFI44L is a novel tumor suppressor in human #hepatocellular #carcinoma affecting cancer stemness, metastasis, and drug resi…

IFI44L is a novel tumor suppressor in human #hepatocellular #carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. https://t.co/HNfZc0WeP0 #BMCCancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.